@FierceMedDev: ICYMI yesterday: Clinicians criticize Baxter for suspending comparative drug/device heart failure trial. Article | Follow @FierceMedDev
@VarunSaxena2: Clinicians criticize Baxter for suspending comparative drug/device heart failure trial. More | Follow @VarunSaxena2
@EmilyWFierce: Report: AstraZeneca funnels billions into Dutch tax-avoidance scheme. FiercePharma story | Follow @EmilyWFierce
> Medtronic ($MDT) is the exclusive sponsor of the new Harvard Business Review Insight Center, which will facilitate conversation around this year's topic: "Measuring Costs and Outcomes in Healthcare." More
> Stentys touted data in support of its sirolimus-eluting Self-Apposing stent at TCT, saying the the rate of well-apposed struts was 99.3%. More
Biotech News
@FierceBiotech: 5 experts, 1 voice: Biotech bubble? It's different this time. Editor's corner | Follow @FierceBiotech
@JohnCFierce: Analysts, experts write off Merck's huge anacetrapib PhIII. Report | Follow @JohnCFierce
@DamianFierce: Entirely baffled by $XON's business model. More | Follow @DamianFierce
> Zafgen shares continue to slide on market fears. Item
> Protalix flips its Gaucher drug to Pfizer for $46M in R&D cash. Report
> FDA misses approval date for Collegium's pain drug. News
Pharma News
@FiercePharma: Japan's Astellas splashes out $300M for Immunomic's LAMP-vax platform. FiercePharmaAsia story | Follow @FiercePharma
@EricPFierce: ICYMI: Sanofi's Kansas City, MO plant back on the block as its August 2016 closing looms. Story | Follow @EricPFierce
@CarlyHFierce: J&J plots $10B buyback as plummeting hep C sales tarnish Q3. Article | Follow @CarlyHFierce
> Former Pfizer chemist and Zoloft co-developer Ken Koe dies at 90. News
> Novo Nordisk chief Sørensen tops world's-best CEO ranking. More
Drug Delivery News
> Study finds EpiPens can injure children, recommends improved technique and design. More
> Russian Academy: Combining drugs with ionic liquids can up the solubility, cut polymorphism. News
> Medicines Co. enters Japanese market, handing over license to transdermal pain patch. Story
> OptiNose bags $30M in VC financing as partner Otsuka barrels toward its second PDUFA date. Article
> 3M takes on blood-brain barrier with Impel Neuropharma nasal drug delivery alliance. Report
Pharma Manufacturing News
> Pests again figure into issues in FDA warning letter to Indian API maker. More
> Cipla's new U.S. plant received Form 483 just ahead of deal. News
> CPhI report predicts growth in outsourcing for sterile injectables. More
> Aurobindo to expand India API plant fourfold. Story
> Hong Kong's gray market draws mainland Chinese looking for lifesaving meds they can't afford at home. Article
Pharma Asia News
> HK-listed 3SBio inks oncology antibody drug deal with South Korea's Alteogen. Story
> CIMB says Malaysian pharmas have scope to adjust to TPP changes. Report
> China's Innovent Biologics deepens pact with Eli Lilly on immuno-oncology. Article
> Japan's Astellas splashes out $300M for Immunomic's LAMP-vax platform. Item
> Hong Kong drugstores attract Chinese customers for cancer, hep C drugs. More